about
Anti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel VasculitisPerspective on future therapy of vasculitis.Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.Eosinophils in vasculitis: characteristics and roles in pathogenesis.Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).Cutting edge issues in the Churg-Strauss syndrome.Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art.Pulmonary vasculature and critical asthma syndromes: a comprehensive review.Diagnostic and therapeutic management of Churg-Strauss syndrome.Dendritic cells overexpressing Fas-ligand induce pulmonary vasculitis in mice.Churg-strauss syndrome in the pediatric age group.Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome.[Hypereosinophilic syndrome and Churg-Strauss syndrome: is it clinically relevant to differentiate these syndromes?].Decreases in the numbers of peripheral blood regulatory T cells, and increases in the levels of memory and activated B cells, in patients with active eosinophilic granulomatosis and polyangiitis.Increased expression of TRAIL receptor 3 on eosinophils in Churg-Strauss syndrome
P2860
Q27490357-7D8E41B6-6926-49F9-A98E-1D6834109BABQ34109103-5EC24E04-B777-443D-BBCA-0A54D4FA7F62Q36183288-5F0EEDEA-B8A8-4B1E-9FD4-80C473EB3C32Q36242795-0EA06D19-8A22-4AD8-ABD7-F1182C4FADEBQ36847447-F187893B-69A5-4E68-9F59-C3492ED82740Q37690935-497156CC-177C-4DB1-AB51-7CCACB840BF0Q37850388-875A1F52-5478-4B66-87F6-F32A738C3356Q38075024-3815D789-1B7B-4D69-B4ED-01CBD71DE68FQ38206113-011F9A80-F538-4309-90F0-740405B1DD96Q39872550-549F41BB-9A77-4D35-B2FE-A37DDBC6523AQ40545622-AFF76388-0F5D-4D04-A78B-1710F3A6D13CQ40617823-CC231503-4CAD-48E0-AD5A-5B7E9C306BB4Q40823074-13D9D460-DD40-4CD2-A1FE-0956FD010068Q46795578-F2956C75-2C48-4B7F-9B54-DCBF3433BB76Q50903151-B213EAA7-C859-4FED-A67D-6A1541F8B322Q56745222-AF3B800A-4A1C-405D-9D3B-F2D7FB5CCE3A
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Involvement of soluble CD95 in Churg-Strauss syndrome.
@ast
Involvement of soluble CD95 in Churg-Strauss syndrome.
@en
type
label
Involvement of soluble CD95 in Churg-Strauss syndrome.
@ast
Involvement of soluble CD95 in Churg-Strauss syndrome.
@en
prefLabel
Involvement of soluble CD95 in Churg-Strauss syndrome.
@ast
Involvement of soluble CD95 in Churg-Strauss syndrome.
@en
P2093
P2860
P1476
Involvement of soluble CD95 in Churg-Strauss syndrome.
@en
P2093
D Häussinger
M Schneider
N Temizkan
U Warskulat
P2860
P304
P356
10.1016/S0002-9440(10)65191-7
P407
P577
1999-09-01T00:00:00Z